Tudor Investment Corp’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-189,038
Closed -$1.04M 3798
2025
Q3
$1.04M Buy
+189,038
New +$926K ﹤0.01% 2244
2025
Q2
Sell
-453,574
Closed -$3.02M 3534
2025
Q1
$3.02M Buy
+453,574
New +$3.45M 0.01% 1085
2024
Q3
Sell
-224,574
Closed -$1.1M 2931
2024
Q2
$1.1M Buy
+224,574
New +$1.35M 0.01% 1412
2023
Q3
Sell
-332,461
Closed -$3.04M 2609
2023
Q2
$3.04M Buy
332,461
+118,476
+55% +$984K 0.04% 675
2023
Q1
$1.59M Buy
213,985
+130,131
+155% +$722K 0.02% 910
2022
Q4
$414K Buy
+83,854
New +$519K 0.01% 1707
2021
Q3
Sell
-84,077
Closed -$2.34M 2641
2021
Q2
$2.34M Buy
+84,077
New +$2.22M 0.04% 498

Other funds holding LFST

Tudor Investment Corp's LFST Position: Q4 2025 in Review

Tudor Investment Corp sold out of Lifestance Health (LFST) in Q4 2025, closing a stake of 189,038 shares — an estimated $1.04M sold.

Tudor Investment Corp first reported a position in LFST in Q2 2021 and held it in 7 quarters. The position peaked at $3.04M in Q2 2023. 204 funds tracked by Wall St. Rank hold LFST as of Q4 2025.

  • Tudor Investment Corp reported no remaining Lifestance Health position as of Q4 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 189,038 Lifestance Health shares in Q4 2025, an estimated $1.04M.
  • Tudor Investment Corp first reported a position in Lifestance Health in Q2 2021 and held it in 7 quarters.
  • Tudor Investment Corp's Lifestance Health position peaked at $3.04M in Q2 2023.
  • 204 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.